100 related articles for article (PubMed ID: 25376956)
1. Possible interplay between interleukin-15 and interleukin-17 into the pathogenesis of idiopathic inflammatory myopathies.
Notarnicola A; Lapadula G; Natuzzi D; Iannone F
Reumatismo; 2014 Nov; 66(3):215-23. PubMed ID: 25376956
[TBL] [Abstract][Full Text] [Related]
2. Correlation between serum levels of IL-15 and IL-17 in patients with idiopathic inflammatory myopathies.
Notarnicola A; Lapadula G; Natuzzi D; Lundberg IE; Iannone F
Scand J Rheumatol; 2015 May; 44(3):224-8. PubMed ID: 25379698
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-35 in idiopathic inflammatory myopathies.
Mann H; Kryštůfková O; Zámečník J; Háček J; Hulejová H; Filková M; Vencovský J; Šenolt L
Cytokine; 2021 Jan; 137():155350. PubMed ID: 33128920
[TBL] [Abstract][Full Text] [Related]
4. The clinical utility of serum IL-35 in patients with polymyositis and dermatomyositis.
Yin L; Ge Y; Yang H; Peng Q; Lu X; Zhang Y; Wang G
Clin Rheumatol; 2016 Nov; 35(11):2715-2721. PubMed ID: 27502600
[TBL] [Abstract][Full Text] [Related]
5. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies.
Lundberg I; Ulfgren AK; Nyberg P; Andersson U; Klareskog L
Arthritis Rheum; 1997 May; 40(5):865-74. PubMed ID: 9153548
[TBL] [Abstract][Full Text] [Related]
6. Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis.
Silva MG; Oba-Shinjo SM; Marie SKN; Shinjo SK
Clin Exp Rheumatol; 2019; 37(4):656-662. PubMed ID: 30620283
[TBL] [Abstract][Full Text] [Related]
7. The role of cytokines, chemokines, and adhesion molecules in the pathogenesis of idiopathic inflammatory myopathies.
Lundberg IE
Curr Rheumatol Rep; 2000 Jun; 2(3):216-24. PubMed ID: 11123062
[TBL] [Abstract][Full Text] [Related]
8. Resistin in idiopathic inflammatory myopathies.
Filková M; Hulejová H; Kuncová K; Pleštilová L; Cerezo LA; Mann H; Klein M; Zámečník J; Gay S; Vencovský J; Senolt L
Arthritis Res Ther; 2012 May; 14(3):R111. PubMed ID: 22577940
[TBL] [Abstract][Full Text] [Related]
9. Serum BAFF in Indian patients with IIM: a retrospective study reveals novel clinico-phenotypic associations in children and adults.
Gupta L; Chaurasia S; Srivastava P; Dwivedi S; Lawrence A; Misra R
Clin Rheumatol; 2018 May; 37(5):1265-1271. PubMed ID: 29516280
[TBL] [Abstract][Full Text] [Related]
10. [Expression of interferon and its correlation with clinical features in idiopathic inflammatory myopathies].
Zu N; Wang GC
Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1157-60. PubMed ID: 21756766
[TBL] [Abstract][Full Text] [Related]
11. Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies.
Grundtman C; Salomonsson S; Dorph C; Bruton J; Andersson U; Lundberg IE
Arthritis Rheum; 2007 Feb; 56(2):674-87. PubMed ID: 17265504
[TBL] [Abstract][Full Text] [Related]
12. [Association between cytokines and trichloroethylene-induced hypersensitivity dermatitis].
Zang D; Yi J; Dong HY; Zhou W; Huang XQ; Duan HW; Bin P; Niu Y; Zheng YX; Dai YF
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Sep; 46(9):836-9. PubMed ID: 23157890
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis.
Lundberg I; Kratz AK; Alexanderson H; Patarroyo M
Arthritis Rheum; 2000 Feb; 43(2):336-48. PubMed ID: 10693873
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of HSPA5 in the serum of patients with inflammatory myopathies--preliminary findings.
Xiao F; Tan JZ; Xu XY; Wang XF
Clin Rheumatol; 2015 Apr; 34(4):715-20. PubMed ID: 25750184
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-18 overexpression as a hallmark of the activity of autoimmune inflammatory myopathies.
Tucci M; Quatraro C; Dammacco F; Silvestris F
Clin Exp Immunol; 2006 Oct; 146(1):21-31. PubMed ID: 16968394
[TBL] [Abstract][Full Text] [Related]
16. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.
Krystufková O; Vallerskog T; Helmers SB; Mann H; Putová I; Belácek J; Malmström V; Trollmo C; Vencovsky J; Lundberg IE
Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284
[TBL] [Abstract][Full Text] [Related]
17. Effects of immunosuppressive treatment on interleukin-15 and interleukin-15 receptor α expression in muscle tissue of patients with polymyositis or dermatomyositis.
Zong M; Loell I; Lindroos E; Nader GA; Alexanderson H; Hallengren CS; Borg K; Arnardottir S; McInnes IB; Lundberg IE
Ann Rheum Dis; 2012 Jun; 71(6):1055-63. PubMed ID: 22267334
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) axis in idiopathic inflammatory myopathies and its association with laboratory and clinical parameters: a pilot study.
Opinc A; Sarnik J; Brzezińska O; Makowski M; Lewandowska-Polak A; Makowska J
Rheumatol Int; 2020 Jul; 40(7):1133-1141. PubMed ID: 32222805
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha in inflammatory myopathies: pathophysiology and therapeutic implications.
Efthimiou P
Semin Arthritis Rheum; 2006 Dec; 36(3):168-72. PubMed ID: 16970978
[TBL] [Abstract][Full Text] [Related]
20. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.
Dastmalchi M; Grundtman C; Alexanderson H; Mavragani CP; Einarsdottir H; Helmers SB; Elvin K; Crow MK; Nennesmo I; Lundberg IE
Ann Rheum Dis; 2008 Dec; 67(12):1670-7. PubMed ID: 18272672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
